Found 4736 articles for: "guttate psoriasis/page/87/ht...<br><a class="
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report
October 2025 | Volume 24 | Issue 10 | Case Reports | 9162 | Copyright © October 2025
A Qualitative Assessment of Chatbots for Common Dermatologic
October 2025 | Volume 24 | Issue 10 | Editorials | 9100 | Copyright © October 2025
Understanding Topical Steroid Withdrawal: Where Are We Now?
October 2025 | Volume 24 | Issue 10 | Features | 1025 | Copyright © October 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | 9215 | Copyright © October 2025
The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review
October 2025 | Volume 24 | Issue 10 | Features | 08749 | Copyright © October 2025
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia
October 2025 | Volume 24 | Issue 10 | Editorials | 09076 | Copyright © October 2025
The Dermatologic Hazards of Nail Product Usage
October 2025 | Volume 24 | Issue 10 | Features | 9039 | Copyright © October 2025
The major dermatologic adverse effect of nail polish that has been reported is an allergic contact dermatitis. This can within the ungual and periungual region, but it can also be diffuse and spr...
Read MoreApremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study
September 2025 | Volume 24 | Issue 9 | Original Article | 891 | Copyright © September 2025
Background: Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia primarily affecting Black women. To date, there are no standardized treatment regimens or appro...
Read MoreNeurocosmetic Post-Procedure Cream for Reducing Patient Discomfort and Enhancing Lower Eyelid Recovery After Ablative Treatments
September 2025 | Volume 24 | Issue 9 | Features | 952 | Copyright © September 2025
Contour Tunable Resurfacing Laser (TRL™) is an erbium: yttrium aluminum garnet (YAG) fully ablative laser commonly used to treat the delicate lower eyelid skin for undereye rejuvenation. Po...
Read MoreStructured Training of Dermatology Residents in the Management of Soft-Tissue Filler-Induced Vascular Complications
September 2025 | Volume 24 | Issue 9 | Original Article | 928 | Copyright © September 2025
Background: Soft-tissue filler injection-related vascular complications (IRVC) can lead to tissue necrosis, vision loss, and stroke. Hyaluronidase-based injections are the mainst...
Read MoreGlucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
September 2025 | Volume 24 | Issue 9 | Original Article | 869 | Copyright © September 2025
Background: Hidradenitis suppurativa is a chronic inflammatory skin condition frequently associated with type 2 diabetes mellitus and obesity. Glucagon-like peptide-1 receptor ag...
Read MoreA Randomized, Double-Blind, Split-Face, Clinical Trial of Angiopoietin-1 Derived Peptide Topical Following Fractional Radiofrequency Microneedling
September 2025 | Volume 24 | Issue 9 | Original Article | 875 | Copyright © September 2025
Background: Energy-based devices are commonly used to improve the appearance of aging skin. Treatments can involve long recovery times, marked by pain, erythema, edema, and purpu...
Read MoreOral Hyaluronic Acid Supplement: Efficacy in Skin Hydration, Elasticity, and Wrinkle Depth Reduction
September 2025 | Volume 24 | Issue 9 | Original Article | 910 | Copyright © September 2025
Background: Hyaluronic acid (HA) is a key component naturally present in the skin and is commonly used in skincare formulations and dermal fillers. Recently, there has been growi...
Read MoreHair Transplantation in Women
September 2025 | Volume 24 | Issue 9 | Original Article | 851 | Copyright © September 2025
Background: Hair transplantation is a widely used treatment for androgenetic alopecia (AGA) and other hair loss conditions, with increasing demand from women in recent years.Read MoreTrichoscopic Images Observed in Popular Head Spa Salons: Are We Headed in the Right Direction?
September 2025 | Volume 24 | Issue 9 | Features | 942 | Copyright © September 2025
Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
September 2025 | Volume 24 | Issue 9 | Case Reports | 938 | Copyright © September 2025
Background: Alopecia universalis (AU) is the most severe form of alopecia areata (AA), characterized by complete scalp and body hair loss. While post-COVID-19 hair loss is often ...
Read MoreEyelid Position and Patient-Reported Aesthetic Outcomes Following Administration of Topical Oxymetazoline: A Prospective Cohort Investigation
September 2025 | Volume 24 | Issue 9 | Original Article | 885 | Copyright © September 2025
Background: Topical oxymetazoline hydrochloride 0.1% is a pharmacologic agent for eyelid elevation.Objective: This study investigates changes in eye...
Read MoreIndirect Tightening of Lower Eyelid Skin Following Poly-L-lactic Acid Treatment of the Cheeks
September 2025 | Volume 24 | Issue 9 | Features | 946 | Copyright © September 2025
Retrospective Review of Dermal Safety Studies of Organic Sunscreens
September 2025 | Volume 24 | Issue 9 | Original Article | 897 | Copyright © September 2025
Background: Sunscreens can reduce skin cancer and sunburn. Recent studies on dermal penetration have raised concerns about the safety of sunscreens with organic ultraviolet (UV) ...
Read MoreDermatological Safety of Cosmetic Products Marketed to Children: Insights on the Sephora Kids Phenomenon
September 2025 | Volume 24 | Issue 9 | Features | 949 | Copyright © September 2025
Media and other results for: "guttate psoriasis/page/87/ht...<br><a class="
No results found
© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
